SCHEMBL4043055

SCHEMBL4043055

CC(=O)N1CCN(CCOc2ccc(NC(=O)COc3ccc(Cl)cc3)cc2-c2ccnn2C)CC1

nearest known ligand 0.81

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 20/20 0.81
HTR2C P28335 17/20 0.81
KCNH2 Q12809 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3944669 0.93 HTR2A (0.69) HTR2AHTR2CKCNH2
SCHEMBL3954217 0.93 HTR2A (0.73) HTR2AHTR2CKCNH2
SCHEMBL4037357 0.92 HTR2A (0.68) HTR2AHTR2CKCNH2
SCHEMBL14385357 0.92 HTR2A (0.70) HTR2AHTR2CKCNH2
SCHEMBL14384630 0.92 HTR2A (0.79) HTR2AHTR2C
SCHEMBL3948999 0.92 HTR2A (0.72) HTR2AHTR2CKCNH2
SCHEMBL4218048 0.91 HTR2A (0.80) HTR2AHTR2C
SCHEMBL3947943 0.90 HTR2A (0.80) HTR2AHTR2CKCNH2
SCHEMBL3949362 0.90 HTR2A (0.65) HTR2AHTR2CKCNH2
SCHEMBL4542099 0.90 HTR2A (0.71) HTR2AHTR2CKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2051978-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2009-04-29 EP disclosed
WO-2007136875-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-11-29 WO disclosed
WO-2007136875-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-11-29 WO disclosed